Aster DM Quality Care Limited
All news and filings related to Aster DM Quality Care Limited.
View all news & filings- Medium impact
Aster DM Quality Care Limited Issues Addendum to AGM Notice for Capital Allocation Framework
Aster DM Quality Care Limited issued an addendum to its 18th AGM notice, scheduled for September 28, 2026. The addendum details a proposed capital allocation framework. Indicative deployment includes ~₹1,900 crore in FY27, ~₹3,000 crore in FY28, and ~₹2,000 crore in FY29 for investments.
Read the summary - Medium impact
Aster DM Subsidiary KIMS Healthcare's Credit Rating Upgraded by ICRA to AA(Stable)
ICRA upgraded KIMS Healthcare Management Limited's credit rating to [ICRA]AA(Stable) from [ICRA]AA-. The upgrade reflects the strengthened credit profile of its parent, Aster DM Quality Care Limited. KHML's revenue grew 23% in FY2026 and operating margin improved to 30.2%. Debt metrics strengthened significantly.
Read the summary - Low impact
Aster DM Quality Care Announces 18th AGM on Sep 28, 2026
Aster DM Quality Care Limited will hold its 18th Annual General Meeting on September 28, 2026, at 11:30 AM IST via Video Conference. The Integrated Annual Report for FY 2025-26 has been dispatched. Remote e-Voting is available from September 25 to September 27, 2026. The cut-off date for voting eligibility is September 21, 2026.
Read the summary - Low impact
Aster DM Quality Care Releases FY25-26 Business Responsibility and Sustainability Report
Aster DM Quality Care has released its Business Responsibility and Sustainability Report (BRSR) for FY2025-26. The report, assured by BDO India, highlights achievements in renewable energy, water reuse, and waste recycling. Social initiatives benefited over 1.2 million individuals, with ₹4.17 crore in subsidized surgeries.
Read the summary - Medium impact
Aster DM Quality Care Limited Announces 18th AGM on Sept 28, 2026, to Adopt FY26 Financials
Aster DM Quality Care Limited will hold its 18th AGM on Sept 28, 2026, to adopt FY26 financials. E-voting is from Sept 25-27. Key proposals include increasing loan/guarantee limits to ₹7,500 Cr (Sec 185) and ₹18,800 Cr (Sec 186) to fund expansion. Mr. T J Wilson's reappointment and cost auditor remuneration are also on the agenda.
Read the summary - Medium impact
Dr. Moopen Family Acquires Additional 0.57% Stake in Aster DM Quality Care for ~₹350 Crore
Dr. Moopen family, through Union (Mauritius) Holdings Ltd., acquired 46.09 lakh equity shares (0.57%) in Aster DM Quality Care for ~₹350.34 crore. The shares were bought at ₹760 each on September 2, 2026. This raises the Moopen family's stake to ~24.58%.
Read the summary - Low impact
Aster DM Quality Care Announces 18th AGM on September 28, 2026, via VC/OAVM
Aster DM Quality Care Limited will hold its 18th AGM on September 28, 2026, at 11:30 AM IST via VC/OAVM. The company has published newspaper ads and will send electronic copies of the AGM notice and FY25-26 Annual Report to registered members. Members are urged to update their email addresses.
Read the summary - Medium impact
Aster DM Subsidiary to Add 184 Beds at Trivandrum Facility with ₹134.4 Crore Investment
Aster DM's subsidiary, KHML, will add 184 beds to its Trivandrum hospital, increasing total capacity to 979 beds. The expansion, costing ₹134.4 crore, is expected by May 2028. Financing will be 70% debt and 30% equity.
Read the summary - Medium impact
Aster DM Quality Care's step-down subsidiaries KEL and SHSPL approved for amalgamation
Aster DM Quality Care's step-down subsidiaries, KEL and SHSPL, have approved an amalgamation scheme. KEL will merge with SHSPL, with an appointed date of April 1, 2026. No cash consideration will be paid; equity shares of SHSPL will be issued in exchange for KEL shares. The merger aims to simplify group structure and improve efficiencies.
Read the summary - Medium impact
Aster DM Subsidiary Acquires 14.21% Stake in Bangladesh's STS Holdings for USD 44.11 Million
Aster DM Quality Care Limited's subsidiary acquired a 14.21% stake in Bangladesh-based STS Holdings Limited for USD 44.11 million (approx. ₹368.6 crore). The acquisition aligns with a merger framework and amalgamation scheme approved by the NCLT. STS Holdings reported a turnover of BDT 10,534.24 million in FY26.
Read the summary - Low impact
Aster DM Quality Care: Newspaper Ad for Postal Ballot Notice Dispatch
Aster DM Quality Care Limited announced via newspaper publication on August 27, 2026, the completion of dispatch for the Notice of Postal Ballot. The notice was sent to shareholders via email.
Read the summary - Medium impact
Aster DM Quality Care Seeks Shareholder Approval for Key Appointments and ESOP Scheme
Aster DM Quality Care is seeking shareholder approval for key leadership appointments, including Mr. Varun Shadilal Khanna as MD & Group CEO with ₹8.10 crore fixed salary. Shareholders will also vote on new directors and revised remuneration for the Executive Chairman (up to ₹12.25 crore) and Executive Director (up to ₹2.00 crore). The company also proposes an Employee Stock Option Scheme. Remote e-voting is open from August 27 to September 25, 2026.
Read the summary - Medium impact
Aster DM Quality Care Receives Trading Approval for 35.35 Cr Equity Shares, Trading Commences Aug 17
Aster DM Quality Care Limited received trading approval for 35,35,51,410 equity shares on August 14, 2026. These shares, allotted as part of a Scheme of Amalgamation, will be listed and available for trading from August 17, 2026.
Read the summary - High impact
Aster DM Quality Care Releases Q1 FY27 Earnings Call Transcript
Aster DM Quality Care released its Q1 FY27 earnings call transcript. The combined entity reported Q1 FY27 revenue of ₹2,597 crore, up 20% YoY, and EBITDA of ₹576 crore, up 30% YoY. Management highlighted successful merger integration, focus on specialty care expansion, and patient-centric innovation. Plans include adding over 4,170 beds in 3-4 years.
Read the summary - Low impact
Aster DM Quality Care Announces Q1 FY27 Unaudited Financial Results
Aster DM Quality Care Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were published on August 6, 2026. Access to the full results is available via QR code, weblink, and the company's website.
Read the summary - Low impact
Aster DM Quality Care Releases Earnings Call Recording for Q1 FY27
Aster DM Quality Care Limited has released the video/audio recording of its earnings call for the quarter ended June 30, 2026. The recording is available on the company's website. This follows their previous announcement on July 31, 2026.
Read the summary - Low impact
Aster DM Quality Care to Participate in Investor Roadshow from Aug 10-14, 2026
Aster DM Quality Care will participate in a non-deal roadshow from August 10-14, 2026, organized by Kotak Mahindra Capital Company. The event, featuring group and one-to-one meetings, will be held virtually and in-person in Mumbai and Singapore. No price-sensitive information will be disclosed.
Read the summary - Medium impact
Aster DM Quality Care to acquire additional 12% stake in UCIMSPL for up to Rs. 40.93 crore
Aster DM Quality Care will acquire up to 12% additional equity in its subsidiary, United CIIGMA Institute of Medical Sciences (UCIMSPL), for up to Rs. 40.93 crore. The company also announced the termination of its management agreement for Aster G. Madegowda Hospital. The 18th AGM is scheduled for September 28, 2026.
Read the summary - Medium impact
Aster DM Quality Care to Convene 18th AGM on Sept 28, Acquires Stake in UCIMSPL
Aster DM Quality Care will hold its 18th AGM on September 28, 2026. The company is terminating its operations and management agreement for Aster G. Madegowda Hospital, Maddur, due to sustained losses. It will also acquire up to an additional 12% equity stake in its subsidiary, United CIIGMA Institute of Medical Sciences, for up to Rs. 40.93 crores.
Read the summary - High impact
Aster DM Quality Care Q1FY27 Revenue up 22% to ₹1,311 Cr, EBITDA up 29% to ₹277 Cr
Aster DM Quality Care reported Q1FY27 revenue of ₹1,311 Cr, up 22% YoY. Operating EBITDA grew 29% to ₹277 Cr, with margins improving to 21.1%. Normalised PAT increased 39% to ₹125 Cr. The combined entity posted Q1FY27 revenue of ₹2,597 Cr (up 20%) and EBITDA of ₹576 Cr (up 30%).
Read the summary - Medium impact
Aster DM Quality Care Q1 FY27 Results: Net Loss of ₹14.30 Crore
Aster DM Quality Care reported a standalone net loss of ₹14.30 crore for Q1 FY27, a significant drop from a profit of ₹80.59 crore in Q1 FY26. Total income rose to ₹764.76 crore. The company incurred ₹109.79 crore in exceptional merger-related expenses. Investments totaling ₹101.49 crore were made in subsidiaries and associates.
Read the summary - Low impact
Aster DM Quality Care Schedules Q1 FY27 Earnings Conference Call for August 5, 2026
Aster DM Quality Care Limited will host an earnings conference call on August 5, 2026, at 6:00 PM IST to discuss the unaudited financial results for the quarter ended June 30, 2026. Management including Dr. Azad Moopen and Mr. Varun Khanna will be present.
Read the summary - Medium impact
Aster DM Quality Care Limited Assigned Crisil AA+/Stable Rating for ₹860.5 Cr Facilities
Aster DM Quality Care Limited's bank facilities totaling ₹860.50 crore have been assigned credit ratings by CRISIL. The long-term facilities received 'CRISIL AA+/Stable' and short-term facilities received 'CRISIL A1+'. This follows the merger of Quality Care India Ltd with the company effective July 1, 2026.
Read the summary - Low impact
Aster DM Healthcare Limited to change name to Aster DM Quality Care Limited on July 28, 2026
Aster DM Healthcare Limited is changing its name to Aster DM Quality Care Limited. The name change will be effective from July 28, 2026. The stock symbol ASTERDM will remain the same.
Read the summary - Medium impact
Aster DM Healthcare Completes Share Allotment Post Amalgamation, Capital Increases
Aster DM Healthcare has allotted 35,35,51,410 equity shares post-amalgamation. The company's capital increased to ₹871.67 crore. The shares will be listed on BSE and NSE.
Read the summary - Low impact
Aster DM Healthcare: Compliance Certificate for Quarter Ended June 30, 2026
Aster DM Quality Care Limited received a compliance certificate for the quarter ended June 30, 2026. The certificate from MUFG Intime India Private Limited confirms adherence to SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory submission.
Read the summary - Low impact
Aster DM Healthcare Changes Name to Aster DM Quality Care Limited
Aster DM Healthcare Limited has been renamed Aster DM Quality Care Limited, effective July 3, 2026. This change follows the Scheme of Amalgamation with Quality Care India Limited and is confirmed by a new Certificate of Incorporation.
Read the summary - High impact
Aster DM Healthcare Completes Merger with Quality Care India, Launches Aster Quality Care
Aster DM Healthcare and Quality Care India Limited have merged to form Aster Quality Care. The combined entity will operate 39 hospitals across 28 cities, with plans to expand to over 15,000 beds. Dr. Azad Moopen is Executive Chairman and Mr. Varun Khanna is MD & Group CEO. The focus is on expanding advanced healthcare access in tier 2 and tier 3 cities.
Read the summary - Medium impact
Aster DM Healthcare Appoints New Directors and Senior Management Post-Amalgamation
Aster DM Healthcare appointed Mr. Varun Khanna as MD & Group CEO and five other directors. Five directors resigned, effective July 1, 2026. Senior management roles were adjusted, with Mr. Hitesh Dhaddha resigning as Chief Investor Relations and M&A Officer. Amendments to the ESOP Scheme 2026 were approved.
Read the summary - Low impact
Aster DM Healthcare: Key Personnel Contact Details for Materiality Disclosures
Aster DM Healthcare has disclosed contact details of its Key Managerial Personnel, including the Managing Director & Group CEO, Group CFO, and Company Secretary, for determining materiality of events and making disclosures to stock exchanges as per SEBI regulations.
Read the summary - Medium impact
Aster DM Healthcare Acquires 3,57,143 Preference Shares in Associate Alfaone Medicals for ₹25 Cr
Aster DM Healthcare acquired 3,57,143 preference shares in associate Alfaone Medicals for ₹25 crore. The shares were subscribed via a rights issue at ₹700 each. This is for general corporate purposes and is a related party transaction approved by the board.
Read the summary - High impact
NCLT Approves Amalgamation Scheme for Aster DM Healthcare and QCIL
The NCLT Hyderabad has sanctioned the amalgamation scheme between Quality Care India Limited and Aster DM Healthcare Limited. The scheme becomes effective upon filing the NCLT order with the Registrar of Companies. QCIL will be dissolved without winding up.
Read the summary - Medium impact
Aster DM Healthcare Acquires 100% Stake in Sarjapur Hospital Subsidiary
Aster DM Healthcare acquired 100% stake in its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, on June 18, 2026. The company acquired 4,50,89,995 equity shares for a cash consideration of ₹45,08,99,950.
Read the summary - Medium impact
Aster DM Healthcare Subsidiary Allots CCPS, Secures Additional Investment
Aster DM Healthcare's subsidiary, ADMPL, allotted 21.4 lakh Series A CCPS and 18.4 lakh Series B CCPS on June 16, 2026. The company is also pursuing further capital through additional CCPS. Aster DM Healthcare's stake in ADMPL will remain above 75% post-conversion.
Read the summary - High impact
Aster DM Healthcare & Quality Care Merge to Form Top 3 Indian Hospital Chain
Aster DM Healthcare and Quality Care India Limited are merging to form a leading hospital chain in India. The combined entity will have 10,623 beds, ₹9,273 crore in revenue, and ₹2,013 crore in operating EBITDA for FY26. Key leadership roles are defined, with Dr. Azad Moopen as Executive Chairman. The merger is expected to be EPS accretive and is targeted for completion in Q1 FY27.
Read the summary - Low impact
Aster DM Healthcare to Participate in Analyst/Investor Meets on June 8 & 9, 2026
Aster DM Healthcare will attend the Kotak India Corporate Day Conference on June 8 and 9, 2026. The meetings will be held in Hong Kong and Singapore, respectively. No unpublished price-sensitive information will be disclosed.
Read the summary - Low impact
Aster DM Healthcare to Participate in BoFA and Citi India Conferences in June 2026
Aster DM Healthcare will attend the BoFA 2026 India Conference on June 3, 2026, and the Citi India Conference 2026 on June 4, 2026. Both events will be in-person in Mumbai and include investor group and one-to-one meetings. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Aster DM Healthcare: Union Investments Declares No New Encumbrance in FY26
Union Investments Pvt. Ltd. declared no new encumbrances were made in FY26, as per SEBI Takeover Regulations. This declaration covers the period beyond previously disclosed encumbrances.
Read the summary - Low impact
Aster DM Healthcare to Participate in Centrum Flagship Virtual Conference on May 21-22
Aster DM Healthcare Limited will participate in the Centrum flagship virtual conference, Nakshatra III, on May 21-22, 2026. The company representatives will attend investor group and one-to-one meetings virtually. The schedule may change, and no unpublished price-sensitive information will be shared.
Read the summary - Medium impact
Aster DM Healthcare Q4 FY26 Earnings Call Transcript Released
Aster DM Healthcare released its Q4 FY26 earnings call transcript. The combined proforma revenue grew 18% to ₹2,361 crore, with EBITDA up 25% to ₹517 crore. Full-year combined revenue reached ₹9,273 crore, up 14%, and EBITDA ₹2,013 crore, up 21%. The merger with Quality Care is nearing completion. Aster's standalone Q4 FY26 revenue grew 18% to ₹1,182 crore, with EBITDA up 26% to ₹244 crore.
Read the summary - Low impact
Aster DM Healthcare: Earnings Call Recording for Q4FY26 Available
Aster DM Healthcare's earnings call recording for the quarter and year ended March 31, 2026, is available online. The call took place on May 1, 2026. The recording can be found on the company's investor relations website.
Read the summary - Low impact
Aster DM Healthcare publishes audited financial results for Q4FY26
Aster DM Healthcare Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results were approved by the Board on April 30, 2026, and audited by Deloitte Haskins & Sells. Full details are available on the company and stock exchange websites.
Read the summary - High impact
Aster DM Healthcare Q4FY26: Revenue Up 18%, EBITDA Up 26%
Aster DM Healthcare's combined proforma entity (Aster+QCIL) reported Q4FY26 revenue of ₹2,361 crore, up 18% YoY. Operating EBITDA grew 25% to ₹517 crore. Standalone revenue was ₹1,182 crore (up 18% YoY), with EBITDA at ₹244 crore (up 26% YoY). The merger is expected to complete in Q1 FY27.
Read the summary - High impact
Aster DM Healthcare Q4 FY26 Revenue Up 18% YoY to ₹1,182 Cr; Merger Progresses
Aster DM Healthcare reported Q4 FY26 revenue of ₹1,182 Cr, up 18% YoY. Operating EBITDA (ex-Kasaragod) grew 31% YoY to ₹253 Cr. On a proforma basis (Aster + QCIL), revenue rose 18% to ₹2,361 Cr and EBITDA increased 25% to ₹517 Cr. The merger with QCIL is progressing and expected to complete by Q1 FY27, with 96.68% shareholder approval.
Read the summary - Medium impact
Aster DM Healthcare Q4 FY26 Results: Board Approves Audited Financials
Aster DM Healthcare's Board approved audited financial results for Q4 FY26 and the full year ended March 31, 2026. Auditors issued an unmodified opinion. Results include standalone and consolidated statements.
Read the summary - Low impact
Aster DM Healthcare Schedules Q4 FY26 Earnings Conference Call for May 1st
Aster DM Healthcare will host an earnings conference call on May 1, 2026, at 11:00 AM IST to discuss audited financial results for Q4 and FY26 ended March 31, 2026. Key management, including Dr. Azad Moopen and Ms. Alisha Moopen, will participate.
Read the summary - Medium impact
Aster DM Healthcare Completes 26% Stake Acquisition in Oyster Green Hybrid Two for ₹5.8 Crore
Aster DM Healthcare and MIMS completed acquiring a 26% stake in Oyster Green Hybrid Two for ₹5.8 crore. The initial agreement was for ₹7 crore, but revised due to cost reduction. Investments were made in two tranches, with the final payment on April 22, 2026. Oyster will build an 18 MWp captive solar power plant.
Read the summary - Medium impact
Aster DM Healthcare: Postal Ballot Results Approved for Director Appointment & Loans
Aster DM Healthcare's postal ballot results show members approved the appointment of Dr. Mandayapurath Azad Moopen as Executive Director with 99.839% in favour. Members also approved granting loans/guarantees under Section 185 with 75.567% in favour. E-voting concluded on April 12, 2026.
Read the summary - Medium impact
Aster DM Healthcare: Nurse Strike in Kerala Ends, Operations Resume
Aster DM Healthcare's Kerala hospitals resume full operations after a nurse strike. The strike caused a revenue loss of ₹5.78 crore. Nursing staff have returned to work following engagements with the United Nurses Association, with legal proceedings ongoing for a final settlement.
Read the summary - Medium impact
Aster DM Healthcare Expands Bengaluru Women & Children Facility with ₹96 Crore Investment
Aster DM Healthcare invested ₹96 crore to expand its Women & Children facility at Aster Whitefield Hospital, Bengaluru. Bed capacity increases from 380 to 539. The new 159-bed facility offers specialized maternal and pediatric care. This expansion is part of Aster's growth strategy in Karnataka.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio